A Study of GC101 TIL in Advanced Melanoma (10hospital)

NCT05098184 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
50
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shanghai Juncell Therapeutics

Collaborators